Lion Biotechnologies Reports First Quarter 2017 Financial Results
SAN CARLOS, CA--(Marketwired - May 01, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported its first quarter 2017 …